$Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysis$
QR Code

QR Code

Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysis

Abstract Aims The optimal timing for prescribing guideline‐directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF) during acute decompensated heart failure (ADHF) remains uncertain. This study evaluated the real‐world impact of early in‐hospital quadrupl...

Full description

Saved in:

Bibliographic Details
Main Authors:	Luis E. Echeverría, Lyda Z. Rojas, Angie Yarlady Serrano‐García, Daniel Botero, Karen Andrea García‐Rueda, Ángela Torres‐Bustamante, Diana Ivonne Cañón‐Gómez, Juan Sebastián Salcedo, Alexandra Hurtado‐Ortiz, Jaime A. Rodríguez, Sergio A. Gómez‐Ochoa
Format:	Article
Language:	English
Published:	Wiley 2025-08-01
Series:	ESC Heart Failure
Subjects:	acute decompensated heart failure GDMT heart failure mortality outcomes
Online Access:	https://doi.org/10.1002/ehf2.15286
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Strategy of selecting the scales of risk, prognosis, and disease severity in patients with acute decompensated heart failure
by: A. G. Arutyunov
Published: (2013-04-01)

Prognostic value of renal function in patients with acute decompensation of chronic heart failure
by: I. A. Meray, et al.
Published: (2008-08-01)

Risk factors for acute decompensated heart failure in type 2 diabetes patients
by: N. A. Koziolova, et al.
Published: (2020-05-01)

Acute decompensated heart failure in patients with prediabetes: relationship with risk factors and comorbidities
by: N. A. Koziolova, et al.
Published: (2023-04-01)

Aquaretics Use in Acute Decompensated Heart Failure (ADHF) Patients: A Literature Review
by: Norman Sukmadi, et al.
Published: (2022-09-01)

Clinico-demographic characteristics of the patients with decompensated chronic heart failure Clinico-demographic characteristics of the patients with decompensated chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2011-04-01)

Furosemide‐hydration matching with RenalGuard® in decompensated heart failure: an alternative way to use diuretics and saline
by: Massimo Mapelli, et al.
Published: (2025-08-01)

Albuminuria as a marker of systemic congestion and a predictor of poor long-term prognosis in acute decompensated heart failure
by: Zh. D. Kobalava, et al.
Published: (2024-05-01)

DECOMPENSATED CHRONIC HEART FAILURE: FROM PATHOGENESIS TO PROGNOSIS
by: K. S. Fazulina
Published: (2016-12-01)

Treatment of iron deficiency in patients after acute decompensation: a new target in the treatment of heart failure
by: I. V. Zhirov, et al.
Published: (2022-06-01)

Prevalence and clinical significance of iron deficiency in patients with acute decompensated heart failure
by: E. A. Smirnova, et al.
Published: (2023-09-01)

Factors associated with the risk of progression and decompensation of heart failure in patients with an implantable cardioverter-defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-04-01)

Practical aspects of vericiguat therapy in patients with heart failure with reduced ejection fraction. Expert council resolution
by: S. A. Boytsov, et al.
Published: (2023-05-01)

Digital model for predicting the risk of developing acute decompensated heart failure
by: N. B. Lebedeva, et al.
Published: (2024-07-01)

Empagliflozin in patients hospitalized for acute decompensated heart failure: an expert resolution on the discussion of the EMPULSE trial
by: Yu. M. Lopatin, et al.
Published: (2022-04-01)

Effect of dapagliflozin on serum N‐terminal fragment-proB‐type natriuretic peptide level in patient with acute decompensated heart failure
by: Hanna Jassim Dohei, et al.
Published: (2025-03-01)

Organoprotective effects of serelaxin in patients with severe decompensated heart failure
by: Z. D. Kobalava, et al.
Published: (2016-09-01)

IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE
by: M. V. Lediakhova, et al.
Published: (2018-05-01)

Management of heart failure patients in Russia: perspectives and realities of the second decade of the XXI century
by: E A Lyasnikova, et al.
Published: (2021-10-01)

PROGNOSTIC IMPACT OF COMMUNITY-ACQUIRED AND HOSPITAL-ACQUIRED HYPONATREMIA IN PATIENTS WITH DECOMPENSATED HEART FAILURE
by: D. Yu. Shchekochikhin, et al.
Published: (2015-09-01)

Heart transplantation in secondary dilated cardiomyopathy due to myocarditis. Case report
by: D. V. Romashova, et al.
Published: (2023-06-01)

Changes of natriuresis and prediction of cardiovascular events in patients with type 2 diabetes and decompensated heart failure over therapy with sodium-glucose cotransporter 2 inhibitors and standard diuretic therapy
by: O. A. Abdullaev, et al.
Published: (2024-03-01)

The Comparison of Clinical Characteristics of Acute Decompensated Heart Failure Patients between JCARE-CARD Japan and dr. Kariadi Hospital Registry
by: Mochamad Ali Sobirin, et al.
Published: (2023-05-01)

Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization
by: D. P. Golubovskaya, et al.
Published: (2023-05-01)

Prognostic value of acute kidney injury in patients hospitalized with acute decompensation of chronic heart failure
by: Zh. D. Kobalava, et al.
Published: (2025-07-01)

IMMUNE RESPONSE IN DECOMPENSATED CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN
by: E. V. Kruchinkina, et al.
Published: (2018-03-01)

Risk factors and diagnostic significance of the N-terminal pro-brain natriuretic peptide as a marker in patients with acute decompensated heart failure and diabetic kidney disease
by: N. A. Koziolova, et al.
Published: (2021-04-01)

SERELAXIN IN THE STRATEGY OF MANAGEMENT THE PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: FROM DECREASING OF SYMPTOMS TO THE IMPROVEMENT OF SURVIVAL
by: I. V. Zhirov, et al.
Published: (2015-09-01)

Influence of standard heart failure therapy on readmission rate: opportunities and limitations in modern clinical practice
by: S. R. Gilyarevsky
Published: (2021-11-01)

Independent and combined associations of high-density lipoprotein cholesterol-modified triglyceride-glucose index with all-cause and cardiovascular mortality in patients with acute decompensated heart failure
by: Shiming He, et al.
Published: (2025-07-01)

Allopurinol in the complex therapy of acute decompensation of heart failure
by: Laura H. Sarieva, et al.
Published: (2025-01-01)

Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study
by: K. V. Charaya, et al.
Published: (2023-01-01)

Decompensated heart failure: a reconceptualization in the light of updated consensus statement of the European Society of Cardiology
by: V. N. Larina, et al.
Published: (2023-12-01)

Impact of immigration on outcomes following acute decompensated heart failure: A retrospective cohort study
by: Gil Marcus, et al.
Published: (2025-08-01)

CARDIORENAL INTERACTION IN DECOMPENSATED CHRONIC HEART FAILURE
by: Zh. D. Kobalava, et al.
Published: (2016-05-01)

Impact of remnant cholesterol on short-term mortality in acute decompensated heart failure: cohort study evidence from Jiangxi, China
by: Guoan Jian, et al.
Published: (2025-08-01)

PREDICTIVE VALUE OF ERYTHROCYTE ANISOTROPY COEFFICIENT IN PATIENTS HOSPITALIZED FOR ACUTELY DECOMPENSATED CHRONIC HEART FAILURE
by: V. A. Kostenko, et al.
Published: (2017-12-01)

Modern approaches to treatment of patients with decompensated chronic heart failure: the role of inflammation in the pathogenesis of decomposition
by: E. V. Kruchinkina, et al.
Published: (2018-12-01)

Accuracy of determination of the volemic status by remote dielectric sensing in comparison with computed tomography with simultaneous determination of respiratory profile using spirometry in patients with acute decompensation of heart failure
by: A. A. Syrkhaeva, et al.
Published: (2024-05-01)

Prediction of early mortality after cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: focus on transthoracic echocardiography
by: N. N. Ilov, et al.
Published: (2023-07-01)